Wolf G, Thaiss F, Scherberich J E, Schoeppe W, Stahl R A
Department of Medicine, University of Frankfurt, Federal Republic of Germany.
Kidney Int. 1990 Nov;38(5):862-8. doi: 10.1038/ki.1990.283.
Angiotensinase A (aminopeptidase A; ATA) is an angiotensin II splitting exopeptidase, which is localized in endothelial and epithelial cells of the glomerular tuft. In order to investigate the influence of a reduction in renal mass on enzyme activity, ATA activity was measured in isolated rat glomeruli five and 14 weeks after 1-1/3 nephrectomy. Glomerular ATA activity in remnant kidneys increased significantly after five weeks following ablation compared with glomeruli of two kidney control rats (5.34 +/- 4.02 vs. 1.71 +/- 1.96 mU/mg protein, P less than 0.05). After 14 weeks, however, this difference was no longer present. Treatment of rats with enalapril or saralasin inhibited the increase of ATA seen five weeks after renal ablation, whereas indomethacin had no effect on enzyme activity. Furthermore, normal two kidney rats, treated with furosemide, revealed a higher glomerular ATA than two kidney controls (5.5 +/- 2.64 vs. 2.1 +/- 1.7 mU/mg protein, P less than 0.05). In vitro superfusion of isolated glomeruli with enalaprilate or furosemide from rats after renal ablation did not influence enzyme activity, however, superfusion with 0.05 mM angiotensin II or 0.05 mM saralasin significantly reduced ATA. Our results suggest that glomerular ATA might be involved in the early regulation of the intrarenal renin-angiotensin system and could modify glomerular adaptation to reduce renal mass by affecting angiotensin II degradation.
血管紧张素酶A(氨肽酶A;ATA)是一种裂解血管紧张素II的外肽酶,定位于肾小球的内皮细胞和上皮细胞中。为了研究肾质量减少对酶活性的影响,在1 - 1/3肾切除术后5周和14周,测定了分离的大鼠肾小球中的ATA活性。与双肾对照大鼠的肾小球相比,切除术后5周,残余肾中的肾小球ATA活性显著增加(5.34±4.02对1.71±1.96 mU/mg蛋白,P<0.05)。然而,14周后,这种差异不再存在。用依那普利或沙拉新治疗大鼠可抑制肾切除术后5周所见的ATA增加,而吲哚美辛对酶活性无影响。此外,用速尿治疗的正常双肾大鼠,其肾小球ATA高于双肾对照大鼠(5.5±2.64对2.1±1.7 mU/mg蛋白,P<0.05)。肾切除术后大鼠的依那普利拉或速尿对分离的肾小球进行体外灌注不影响酶活性,然而,用0.05 mM血管紧张素II或0.05 mM沙拉新灌注可显著降低ATA。我们的结果表明,肾小球ATA可能参与肾内肾素 - 血管紧张素系统的早期调节,并可能通过影响血管紧张素II的降解来改变肾小球对肾质量减少的适应性。